AI Visibility Scorecard
BridgeBio Oncology Therapeutics
bbotx.com · Technology
At 3.13/10, BridgeBio Oncology Therapeutics is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are E-E-A-T Signals, Domain Trust and News Mentions. That is fixable, and the signals below show where to start.
AI engines read this profile 8 times
Claude · Meta AI · Parallel · Amazon Alexa
Top 25% in Technology for AI visibility
44
AI Naming Predictability
iRarely named · 44/100
Technology average 28
Top 20% of Technology
See what's behind this score →3.13
5.2
Network Authority
iConnected · 5.2/10
10 relationships on record. The bigger your network, the more likely AI picks you.
See what's behind this score →30
Muse Index Score
iAI agent readiness
Basic · 30/100
Technology average 17
See what's behind this score →0
Relationship details
See the customers, suppliers and partners named in annual reports →
About BridgeBio Oncology Therapeutics
from our crawl and measurement
BridgeBio Oncology Therapeutics describes itself simply: "Redefining what’s possible in precision oncology to treat RAS-dependent cancers. Taking Precision Oncology to New Heights." When AI engines look at it, they find little to work with. It scores 3.13 out of 10.
Our crawl found structured data on the page (BreadcrumbList, Organization, WebPage), an llms.txt file for AI models and a sitemap. It is missing a heading structure that lays out what it offers.
AI crawlers have read this profile 8 times in our tracking, including ClaudeBot (Anthropic), Meta AI and ShapBot (Parallel).
- Company ·
- BridgeBio Oncology Therapeutics
- Website ·
- bbotx.com
- Industry ·
- Technology
- Site status ·
- Live (The website showed an active business site when last checked (Oct 31, 2026).)
- Last scored ·
- Nov 9, 2026
The 6 on-page signals AI reads
Strong · Good · Fair · Weak
Structured Data
Good
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Strong
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
The 6 off-page signals AI reads
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
-
Not yet measured.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 3.13/10, BridgeBio Oncology Therapeutics is near-invisible to AI engines today. That is fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for BridgeBio Oncology Therapeutics
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
Why your brand doesn't show up in ChatGPT answers (and how to fix it)
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for BridgeBio Oncology Therapeutics.
Source & Attribution
Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/bbotx
Cite this score: Engagemii (2026). "AEO Score for BridgeBio Oncology Therapeutics." Retrieved from https://engagemii.com/aeo/brands/bbotx
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform